Premier Biomedical Competitors and Similar CompaniesClear all

Premier Biomedical's competitors and similar companies include Chiesi Group, UCB, Cipla and Cadila Pharmaceuticals.

	Premier Biomedical Premier Biomedical, a research-based firm, develops medical products for Alzheimer's disease, traumatic brain injury, and more.	Chiesi Group Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.	Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.	Cadila Pharmaceuticals Cadila Pharmaceuticals is a company that develops and manufactures medicines for patients.
Founding Date	Founding Date 2010	Founding Date 1935	Founding Date 1928	Founding Date 1935	Founding Date 1951
Type	Type Public	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Jackson Center, US HQ	Locations Parma, IT HQ Melbourne, AU Wien, AT Machelen, BE Santana De Parnaíba, BR São Paulo, BR Sofia, BG see more	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more	Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more	Locations Bavla, IN HQ Akaki, ET Dholka, IN Chiyoda City, JP Nairobi, KE Moskva, RU Ascot, GB see more
Employees	Employees 2	Employees 5,8541% increase	Employees 9,052	Employees 27,764	Employees 8,5201% increase
Valuation ($)	Valuation ($) 1 m	Valuation ($) N/A	Valuation ($) 34.3 b	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $14.3k (FY, 2019)	Revenue (est.) €2.4b (Y, 2021)	Revenue (est.) €7.4b (FY, 2025)	Revenue (est.) ₹277.1b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods $12.9k (FY, 2019)	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)	Cost of goods ₹95.5b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit $1.4k (FY, 2019)	Gross profit N/A	Gross profit €7.2b (FY, 2025)	Gross profit ₹195b (FY, 2026)	Gross profit N/A
Net income	Net income ($374.5k) (FY, 2019)	Net income N/A	Net income €1.6b (FY, 2025)	Net income ₹38.7b (FY, 2026)	Net income N/A
Operating ⚠
Manufacturing Sites	Manufacturing Sites N/A	Manufacturing Sites 3 (Y, 2021)	Manufacturing Sites N/A	Manufacturing Sites 46 (FY, 2024)	Manufacturing Sites N/A

For sources of this data, please see the company profile

View Company Profiles

Chiesi Group

Parma, IT

Chiesi Group (Gruppo Chiesi, also known as CHIESI Farmaceutici) is a company that researches, develops, produces, and commercializes therapeutic solutions.

View company

UCB

Brussels, BE

Employees

9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company

Cipla

Mumbai, IN

Employees

27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.